Metraipolis › archive › dc_7d3ea8ce19a2
Plasma Proteome-Driven Liquid Biopsy for Individualized Monitoring and Risk Stratification of Immune-Related Adverse Events in Checkpoint Immunotherapy — Europe PMC PMID:41391830
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41391830
- DOI
- 10.1016/j.mcpro.2025.101488
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-07T16:15:15.646Z
- SHA-256 of the archived text
cc003d5927d57f302f710d1a8c22c20d673b4340d0a714e0db745b79dffdb671- Stable URL of this page
https://metraipolis.com/documento/dc_7d3ea8ce19a2
How to cite
Plasma Proteome-Driven Liquid Biopsy for Individualized Monitoring and Risk Stratification of Immune-Related Adverse Events in Checkpoint Immunotherapy — Europe PMC PMID:41391830 — Europe PMC (en), https://europepmc.org/article/MED/41391830 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_7d3ea8ce19a2 (Metraipolis archive dc_7d3ea8ce19a2, sha256 cc003d5927d57f302f710d1a8c22c20d673b4340d0a714e0db745b79dffdb671)
BibTeX
@misc{dc7d3ea8ce19a2,
title = {Plasma Proteome-Driven Liquid Biopsy for Individualized Monitoring and Risk Stratification of Immune-Related Adverse Events in Checkpoint Immunotherapy — Europe PMC PMID:41391830},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41391830},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_7d3ea8ce19a2; sha256 cc003d5927d57f302f710d1a8c22c20d673b4340d0a714e0db745b79dffdb671},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41391830. Agents can read the archived copy with the MCP tool read_document.